4 Jan 2023 13:42
4 January 2023
Medica Group Plc
Issue of Equity and Block Listing Six Monthly Return
Medica Group PLC (LSE:MGP, "Medica" or the "Company"), the UK market leader in the provision of teleradiology services, has allotted and issued 200,000 ordinary shares of 0.2 pence each in the capital of the Company ("New Ordinary Shares"). The New Ordinary Shares were issued to the trustee of the Company's Employee Benefit Trust and will be used to satisfy awards and options vesting in the Medica Group PLC Performance Share Plan 2017.
Applications have been made for admission of the New Ordinary Shares to the premium listing segment of the Official List of the Financial Conduct Authority of the United Kingdom (the "FCA") and to trading on the London Stock Exchange plc's (the "London Stock Exchange") main market for listed securities (together, "Admission"). It is expected that Admission will become effective and that dealings will commence in the New Ordinary Shares at 8.00 a.m. on 5 January 2023. The New Ordinary Shares will rank pari passu with the existing ordinary shares in issue.
Following Admission, the Company will have 122,633,635 ordinary shares in issue.There are no ordinary shares held in treasury. Therefore, the Company hereby confirms that, following Admission, the total number of voting rights in the Company will be 122,633,635. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
Name of applicant: | Medica Group plc | ||||
Name of scheme: | 2019 Sharesave Scheme | ||||
Period of return: | From: | 1 July 2022 | To: | 31 December 2022 | |
Balance of unallotted securities under scheme(s) from previous return: |
8,399 ordinary shares of 0.2 pence each | ||||
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | - | ||||
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | 4,799 ordinary shares of 0.2 pence each | ||||
Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 3,600 ordinary shares of 0.2 pence each | ||||
Name of contact: | Richard Jones, Chief Financial Officer | ||||
Telephone number of contact: | +44 (0)33 33 111 222 | ||||
For further information, please contact:
Medica Group Plc: Stuart Quin, Chief Executive Officer Richard Jones, Chief Financial Officer
| +44 (0)33 33 111 222
|
FTI Consulting Victoria Foster Mitchell Sam Purewal
| +44 (0)20 3727 1000 |
Liberum (Joint Broker) Phil Walker Richard Lindley
| +44 (0)20 3100 2000 |
Numis (Joint Broker) Freddie Barnfield Duncan Monteith Euan Brown
| +44 (0)20 7260 1000
|
About Medica Group PLC
Medica (LSE:MGP) is an international provider of high-quality telemedicine services. It is the market leader in teleradiology in the UK and Ireland, working with more than 100 NHS Trusts and HSE hospitals in Ireland, in addition to private hospitals, insurance groups and diagnostic imaging companies. Its network of consultant radiologists, radiographers and specialist doctors interpret and report MRI, CT, ultrasound and X-ray images on behalf of healthcare providers, using Medica's bespoke, secure technology platform for fast and responsive delivery. The company's core services include NightHawk, an urgent, out-of-hours offering available to clients 24/7 with dedicated pathways for stroke and major trauma, and Elective, for routine reporting.
In Ireland, Medica carries out patient scanning, as well as reporting, and runs a diabetic retinopathy screening programme for the National Screening Service. Through its US business, RadMD, Medica provides global pharmaceutical and biotech companies, as well as contract research organisations with specialist imaging services for clinical trials.
For more information please visit: www.medicagroupplc.com